Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome

References

• Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50: 113–6.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–74.
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141–6.
   Google Scholar
• Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165–9.
   PubMed Web of Science ®Google Scholar
• Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyanathan R, Bush A et al. Dyslipidemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 1996; 44: 277–84.
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long term follow up focusing on natural history and circulating hormones. Fertil Steril 1992; 57: 505–13.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos J, Perez-Bravo F. Prevalence of type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 2002; 45: 959–64.
   Google Scholar
• Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first- degree relatives of patients with PCOS. Fertil Steril 2001; 75: 53–8.
   Google Scholar
• Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, eds. Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific, 1992: 377–84.
   Google Scholar
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002; 25: 5S–20.
   Google Scholar
• Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 2001; 18: 126–32.
   Google Scholar
• Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
   PubMed Web of Science ®Google Scholar
• Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708–23.
   PubMed Web of Science ®Google Scholar
• Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 2000; 73: 724–9.
   Google Scholar
• Cibula D, Skrha J, Hill M, Fanta M, Haakova L, VrbIkova J et al. Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 5821–5.
   PubMed Web of Science ®Google Scholar
• Franks S, Kiddy D, Hamilton-Fairley D, Bush A, Sharp PS, Reed MJ. The role of nutrition and insulin in the regulation of sex hormone binding globulin. J Steroid Biochem Mol Biol 1991; 39: 835–8.
   Google Scholar
• Pasquali R, Gambineri A, Anconcetani B, Vicennati V, Colitta D, Caramelli E et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol 1999; 50: 517–27.
   PubMed Web of Science ®Google Scholar
• Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J, Skibova J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 2000; 15: 785–9.
   PubMed Web of Science ®Google Scholar
• Lindahl B, Weinehall L, Asplund K, Hallmans G. Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care 1999; 22: 1988–92.
   PubMed Web of Science ®Google Scholar